🧠AI AnalysisFDA Approves Roche's New Breast Cancer Treatment Wilserdly
The Food and Drug Administration has cleared Roche's new oral therapy Wilserdly for specific advanced breast cancer patients, marking an important regulatory milestone fo…
🧠AI AnalysisThe Food and Drug Administration has cleared Roche's new oral therapy Wilserdly for specific advanced breast cancer patients, marking an important regulatory milestone fo…
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.